MALIK FADY IBRAHAM (EVP Research & Development) sold 2.2% of their position (3.50K shares) of CYTOKINETICS INC on the open market
Open‑market sale worth $270.8K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/5/2026ACC: 0001061983-26-000051
Officer· EVP Research & Development
Since Jul 2018
-3.50K
Net shares
Net seller
$270.8K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
3.50K acquired · 7K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+3.50K
Price / share
$7.80
Trade value
$27.30K
% of position
2.3%
5/5/2026
153.90K→157.40K
Common Stock
Direct
Shares
−3.50K
Price / share
$77.37
Trade value
$270.80K
% of position
2.2%
5/5/2026
157.40K→153.90K
Total
Net shares
+0.00
Net value
-$243.50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/5/2026 | M · Option Exercise | +3.50K | $7.80 | $27.30K | 2.3% | 153.90K | 157.40K |
| Common Stock Direct | 5/5/2026 | S · Sale | −3.50K | $77.37 | $270.80K | 2.2% | 157.40K | 153.90K |
| Total | +0.00 | -$243.50K | ||||||
Derivative Transactions1
Non-Qualified Stock Option (Right to Buy)
Direct
Converts to
Common Stock
3.50K shares
Shares
−3.50K
Strike price
7.80
Held after
51.39K
Exercisable
—
5/5/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (Right to Buy) Direct | Common Stock3.50K shares | 5/5/2026 | M · Option Exercise | −3.50K | 7.80 | — | 51.39K |